Insights

Innovative Oxygen Technology Belluscura specializes in advanced oxygen enrichment devices and therapies, creating opportunities to target healthcare providers and clinics seeking cutting-edge respiratory solutions for COPD and wound care patients.

Recent Funding & Growth With recent strategic financings totaling over 12 million dollars, Belluscura is expanding its product portfolio and market reach, presenting opportunities to collaborate on new medical devices and potentially co-develop solutions.

Expanding Market Reach The appointment of new leadership in North American sales and the launch of digital health integrations like the Bluetooth-enabled X-PLOR position Belluscura to penetrate and grow within the North American respiratory device market.

Strategic Partnerships Belluscura's joint ventures and collaborations in developing oxygen-based wound care open avenues for sales partnerships with medical device companies and healthcare providers focused on innovative therapeutic solutions.

Global Disease Impact Addressing COPD, which affects over 100 million worldwide, suggests significant long-term sales opportunities across global markets, especially with healthcare systems prioritizing respiratory and chronic disease management.

Similar companies to Belluscura

Belluscura Tech Stack

Belluscura uses 8 technology products and services including Open Graph, WordPress, JSON-LD, and more. Explore Belluscura's tech stack below.

  • Open Graph
    Content Management System
  • WordPress
    Content Management System
  • JSON-LD
    Javascript Frameworks
  • Vue.js
    Javascript Frameworks
  • TweenMax
    Javascript Frameworks
  • Moment.js
    Javascript Libraries
  • Priority Hints
    Performance
  • prettyPhoto
    Web Tools And Plugins

Media & News

Belluscura's Email Address Formats

Belluscura uses at least 1 format(s):
Belluscura Email FormatsExamplePercentage
First.Last@belluscura.comJohn.Doe@belluscura.com
41%
FLast@belluscura.comJDoe@belluscura.com
9%
First.Last@belluscura.comJohn.Doe@belluscura.com
41%
FLast@belluscura.comJDoe@belluscura.com
9%

Frequently Asked Questions

What is Belluscura's phone number?

Minus sign iconPlus sign icon
You can contact Belluscura's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Belluscura's stock symbol?

Minus sign iconPlus sign icon
Belluscura is a publicly traded company; the company's stock symbol is BELL.L.

What is Belluscura's official website and social media links?

Minus sign iconPlus sign icon
Belluscura's official website is belluscura.com and has social profiles on LinkedIn.

What is Belluscura's NAICS code?

Minus sign iconPlus sign icon
Belluscura's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Belluscura have currently?

Minus sign iconPlus sign icon
As of December 2025, Belluscura has approximately 21 employees across 2 continents, including North AmericaEurope. Key team members include Ceo: B. R.Chief Operating Officer: B. B.Chief Financial Officer: A. D.. Explore Belluscura's employee directory with LeadIQ.

What industry does Belluscura belong to?

Minus sign iconPlus sign icon
Belluscura operates in the Medical Equipment Manufacturing industry.

What technology does Belluscura use?

Minus sign iconPlus sign icon
Belluscura's tech stack includes Open GraphWordPressJSON-LDVue.jsTweenMaxMoment.jsPriority HintsprettyPhoto.

What is Belluscura's email format?

Minus sign iconPlus sign icon
Belluscura's email format typically follows the pattern of First.Last@belluscura.com. Find more Belluscura email formats with LeadIQ.

How much funding has Belluscura raised to date?

Minus sign iconPlus sign icon
As of December 2025, Belluscura has raised $12M in funding. The last funding round occurred on Aug 02, 2019 for $2.7M.

When was Belluscura founded?

Minus sign iconPlus sign icon
Belluscura was founded in 2016.

Belluscura

Medical Equipment ManufacturingTexas, United States11-50 Employees

Belluscura was established in the U.K. as a medical device company focused on developing oxygen enrichment technology to help improve health for Chronic Obstructive Pulmonary Disease (COPD) patients and more favorable economic outcomes for the patient, provider, and insurance companies. COPD is the third leading cause of death in the United States, affecting approximately 30 million people in the U.S. and over 100 million worldwide. Belluscura, now with North American headquarters located in Texas, is dedicated to developing proprietary, patented oxygen enrichment technologies that can be applied across a range of treatment possibilities and positively impact millions of people across the globe.

Section iconCompany Overview

Phone number
Stock Symbol
BELL.L
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $12M

    Belluscura has raised a total of $12M of funding over 5 rounds. Their latest funding round was raised on Aug 02, 2019 in the amount of $2.7Mas a financing round.

  • $1M$10M

    Belluscura's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $12M

    Belluscura has raised a total of $12M of funding over 5 rounds. Their latest funding round was raised on Aug 02, 2019 in the amount of $2.7Mas a financing round.

  • $1M$10M

    Belluscura's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.